<?xml version="1.0" encoding="UTF-8"?>
<p>Due to the somewhat reduced clinical benefits of the drugs mentioned above in the treatment of skin lesions caused by herpes simplex viruses, new therapeutic alternatives have emerged in the most recent years. One of these alternatives is a combination of acyclovir and hydrocortisone for topical use (Xerese
 <sup>Â®</sup>, Medivir). This formulation reduces the duration of herpetic lesions by 1.6 days (compared to 1.0 days by acyclovir when applied alone as a topic in that study) and reduces the size of the lesion area by 50% (
 <xref rid="B181" ref-type="bibr">Strand et al., 2012</xref>). While this approach yields a statistically significant improvement in the treatment of herpetic lesions, it still evidences the need for identifying new drugs or drug combinations that have even better effectiveness.
</p>
